← Back to Blog
Ro vs Hims for GLP-1 Weight Loss: Which Is Better in 2026?
ComparisonApril 3, 202612 min read

Ro vs Hims for GLP-1 Weight Loss: Which Is Better in 2026?

Ro and Hims are two of the most recognized names in telehealth — and both now offer GLP-1 weight loss programs with branded Wegovy. But they work very differently: Ro accepts insurance and runs a dedicated obesity program, while Hims is cash-pay only and recently survived a lawsuit from Novo Nordisk over compounded medications. Here's how they actually compare in April 2026.

The Quick Verdict

Bottom line: Choose Ro if you have insurance or want comprehensive clinical support (monthly check-ins, nutrition counseling, health coaching). Choose Hims if you want the lowest cash-pay entry price ($39 first month) and prefer a straightforward, no-insurance process. Both now offer branded Wegovy.

Pricing: What You'll Actually Pay

RoHims
Membership (1st month)$45$39
Membership (ongoing)$145/mo$149/mo
Wegovy pill$149-299/mo$149/mo+
Wegovy pen (cash)AvailableAvailable
Wegovy pen (insurance)Yes — as low as $25/moNot accepted
Zepbound$449/mo via LillyDirectNot listed
Foundayo (oral, Apr 2026)$149-299/moTBD
Compounded semaglutideAvailable in some statesLimited — clinically necessary only

The biggest pricing difference: Ro accepts insurance. If your commercial insurance covers Wegovy, Ro's insurance concierge handles the prior authorization process for you. With a manufacturer savings card, your cost could drop to $25/month. Hims is strictly cash-pay — no insurance accepted, though FSA/HSA cards work.

For uninsured patients, pricing is close. Both offer the Wegovy pill starting around $149/month. Ro's membership is slightly cheaper ($145 vs $149/month ongoing), but Hims offers lower first-month pricing ($39 vs $45).

Medications Available

Both platforms expanded their medication offerings significantly in early 2026:

  • Ro offers: Wegovy pill, Wegovy pen, Ozempic, Zepbound ($449/mo via LillyDirect integration), Foundayo (starting April 6, 2026), and compounded options in select states
  • Hims offers: Wegovy pill (1.5mg, 4mg, 9mg, 25mg tablets), Wegovy pen (1.7mg, 2.4mg), Ozempic (0.5mg, 1mg, 2mg), and limited compounded semaglutide only when clinically necessary
  • Key difference: Ro has Zepbound (tirzepatide) and Foundayo (orforglipron) — Hims does not appear to offer either as of April 2026

Ro launched the Wegovy pill on January 5, 2026 — among the first telehealth platforms to offer it. Ro positions itself as a dedicated weight management platform, while Hims is a broader men's health platform that added GLP-1s to their existing hair loss, ED, and skincare offerings.

The Hims + Novo Nordisk Saga (Important Context)

The Hims-Novo relationship is a dramatic story that matters for understanding what you're getting today:

  • April 2025: Hims and Novo Nordisk announced a partnership to sell branded Wegovy on Hims at $599/month
  • June 2025: Novo terminated the deal after ~1 month, accusing Hims of continuing to sell compounded semaglutide made with unauthorized ingredients. Hims stock dropped 30%.
  • February 2026: Hims launched a $49/month compounded Wegovy pill copy. Novo immediately sued for patent infringement.
  • March 9, 2026: New deal reached. Novo dropped the lawsuit. Hims agreed to stop advertising compounded GLP-1s and offer branded Wegovy and Ozempic at standard prices. Compounded versions are only available when a provider deems it clinically necessary.
What this means for you: The compounded GLP-1 era on Hims is effectively over. If you join Hims today for weight loss, you'll get branded Wegovy or Ozempic — the same FDA-approved medications as everywhere else. The $49 compounded pill is no longer available.

Clinical Support

FeatureRoHims
ConsultationFree async, 24hr provider reviewOnline assessment
Ongoing supportMonthly check-ins, unlimited messaging24/7 provider access, quarterly reviews
Health coachingIncludedNot included
Nutrition counselingIncludedNot included
Exercise planningIncludedNot included
Lab workMetabolic labs may be requiredNot required
Insurance conciergeYes — handles prior authN/A (no insurance)

Ro's clinical model is more comprehensive — it's a dedicated weight management program with health coaching, nutrition, and exercise support built in. Hims offers provider access and check-ins but positions the medication as the primary intervention. If you want a hands-on program that goes beyond the prescription, Ro delivers more value. If you want straightforward medication access without extras, Hims is simpler.

User Reviews

Ro has a 3.7/5 rating on Trustpilot from 3,131 reviews. Common positives: convenience, provider communication, significant weight loss. Common negatives: customer service frustrations, delivery delays, and confusion about membership ($145) being separate from medication cost.

Hims has a 4.4/5 on Trustpilot from 32,000+ reviews across all products (4.1/5 for weight loss specifically). Positives: effective medication, easy process. Negatives: shipping delays, prescription refill delays, and prepaid no-refund policy frustrating users who want to cancel.

Watch out: Both platforms use prepaid plans with limited refund options. Ro offers annual savings on Wegovy pen ($100/month off). Hims locks you into 3, 6, or 12-month bundles. Read the refund policy before committing to a long-term plan on either platform.

Who Should Choose Ro

  • You have commercial insurance that might cover Wegovy — Ro handles prior authorization for you
  • You want comprehensive clinical support (coaching, nutrition, exercise planning)
  • You want access to Zepbound or the new Foundayo pill alongside Wegovy
  • You prefer a platform focused entirely on weight management

Who Should Choose Hims

  • You're paying cash and want the lowest entry point ($39 first month)
  • You want a simple process — no insurance paperwork, no lab requirements
  • You already use Hims for other health products and want one platform
  • You want branded Wegovy pill or pen without comprehensive program extras

Our Ranking

In our provider rankings, Ro scores 8.6/10 (ranked #5) and Hims is not currently in our top 31 as a standalone GLP-1 provider. Ro's higher score reflects its insurance acceptance, broader medication options (Zepbound, Foundayo), and more comprehensive clinical support model. Both are legitimate platforms backed by licensed US physicians.

Not sure which is right for you? Take our match quiz to get personalized recommendations based on your budget, insurance status, and preferences, or use the cost calculator to estimate what you'd actually pay.

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting any medication. Information is current as of the publication date but may change.

Affiliate Disclosure: Some links in this article are affiliate links. We may earn a commission if you sign up through our links, at no extra cost to you.

Find Your GLP-1 Provider

Compare 30+ verified providers side-by-side.